Sunday 11 October 2026 Export all AZN data to Excel Powerpack

AstraZeneca PLC

AZN Healthcare Drug Manufacturers General

AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024. In the quarter to June 2026, revenue grew 6.41%, EPS grew 1.90%, free cash flow fell 107.5% and total debt fell 5.50%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five; insiders bought in the last twelve months.

159.20 0.42 +0.26%

Follow AZN

Alert me

Market cap: $246.3B
P/E: 23.6×
Fwd P/E: 23.4×
Dividend yield: 2.02%
F-score: 9/9
Altman Z: 6.26
Beneish M: −2.51
Dividend safety: 54/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	21.95%	23.47%	22.83%	21.66%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	8	9	8	7
ROA Full definition →	9.15%	9.43%	9.38%	8.57%
ROIC Full definition →	11.67%	12.48%	12.15%	11.65%
Return on Tangible Assets Full definition →	104.18%	102.21%	92.38%	117.93%
Average Days of Receivables Full definition →	95.10	91.58	101.50	95.15
Free Cash Flow per Share Full definition →	4.04	5.13	2.84	6.25
Free Cash Flow Full definition →	6,265.00	7,939.00	8,819.00	9,691.00
Capital Expenditures Full definition →	(7,435.00)	(6,282.00)	(5,756.00)	(5,449.00)
Other line items
Cash ROIC Full definition →	7.38%	9.11%	10.71%	11.40%
Accounts Receivable Turnover Full definition →	3.94	4.03	3.77	4.05
Accounts Payable Turnover Full definition →	0.47	0.49	0.45	0.44
Inventory Turnover Full definition →	1.66	1.78	1.80	1.67
Average Days of Payables Full definition →	751.43	742.03	867.79	892.11
Days of Inventory on Hand Full definition →	227.53	216.63	225.08	235.00
Tax Rate Full definition →	(0.17)	(0.20)	(0.17)	(0.18)
Research and Development Expense of Revenue Full definition →	24.56%	24.10%	24.23%	25.89%
Selling, General and Administrative Expense of Revenue Full definition →	35.42%	34.66%	34.92%	35.13%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	8.06	8.24	8.11	7.75
Operating CF/Net income Full definition →	1.31	1.37	1.43	1.61
Depreciation/Fixed assets Full definition →	0.47	0.44	0.44	0.54
Capex/Depreciation Full definition →	(1.17)	(1.08)	(1.00)	(0.83)
Revenue per Share Full definition →	39.57	39.02	18.95	37.48
Operating CF per Share Full definition →	8.83	9.18	4.70	9.76
Capex per Share Full definition →	(4.79)	(4.06)	(1.86)	(3.51)
Capex to Sales Full definition →	0.12	0.10	0.10	0.09

Fold the line items

Columns are period end dates

Stockrow Weekly